NASDAQ:RCM R1 RCM (RCM) Stock Price, News & Analysis $13.00 +0.09 (+0.70%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$12.87▼$13.0950-Day Range$10.90▼$13.4352-Week Range$8.87▼$18.53Volume1.71 million shsAverage Volume3.11 million shsMarket Capitalization$5.48 billionP/E RatioN/ADividend YieldN/APrice Target$16.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Get R1 RCM alerts: Email Address R1 RCM MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.60 Rating ScoreUpside/Downside23.0% Upside$16.00 Price TargetShort InterestBearish7.53% of Float Sold ShortDividend StrengthN/ASustainability-1.33Upright™ Environmental ScoreNews Sentiment0.25Based on 14 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($0.20) to $0.07 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.3.98 out of 5 starsBusiness Services Sector73rd out of 317 stocksManagement Services Industry2nd out of 6 stocks 3.3 Analyst's Opinion Consensus RatingR1 RCM has received a consensus rating of Moderate Buy. The company's average rating score is 2.60, and is based on 9 buy ratings, 6 hold ratings, and no sell ratings.Amount of Analyst CoverageR1 RCM has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about R1 RCM's stock forecast and price target. Previous Next 1.0 Short Interest Percentage of Shares Shorted7.53% of the float of R1 RCM has been sold short.Short Interest Ratio / Days to CoverR1 RCM has a short interest ratio ("days to cover") of 4.9.Change versus previous monthShort interest in R1 RCM has recently increased by 3.52%, indicating that investor sentiment is decreasing. Previous Next 0.0 Dividend Strength Dividend YieldR1 RCM does not currently pay a dividend.Dividend GrowthR1 RCM does not have a long track record of dividend growth. Previous Next 3.6 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreR1 RCM has received a 45.11% net impact score from Upright. R1 Rcm seems to create the most significant positive value in categories "Jobs", "Taxes", and "Physical diseases". The positive contribution in the "Physical diseases" impact category is mostly driven by its "Documentation software for clinicians", "Personal health record software", and "Hospital cost management software" products. See details.Environmental SustainabilityThe Environmental Impact score for R1 RCM is -1.33. Previous Next 2.9 News and Social Media Coverage News SentimentR1 RCM has a news sentiment score of 0.25. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.57 average news sentiment score of Business Services companies.News Coverage This WeekMarketBeat has tracked 14 news articles for R1 RCM this week, compared to 5 articles on an average week.Search Interest3 people have searched for RCM on MarketBeat in the last 30 days. This is an increase of 50% compared to the previous 30 days.MarketBeat Follows3 people have added R1 RCM to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days. Previous Next 3.3 Company Ownership Insider Buying vs. Insider SellingIn the past three months, R1 RCM insiders have not sold or bought any company stock.Percentage Held by Insiders36.80% of the stock of R1 RCM is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions61.10% of the stock of R1 RCM is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about R1 RCM's insider trading history. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for R1 RCM are expected to grow in the coming year, from ($0.20) to $0.07 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of R1 RCM is -162.56, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of R1 RCM is -162.56, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioR1 RCM has a P/B Ratio of 1.98. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about R1 RCM's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad WealthPressNew trading system called MSFT, NVDA & MSFTLook 2023 kind of sucked from a trading standpoint… Despite the market finishing 24% higher…. Just seven stocks did all of the work… Unless you were holding or actively trading those 7 stocks, your trading year probably wasn’t as fruitful as you had hoped… According to my research, my new trading system would have spotted all seven of the “Magnificent stocks” MONTHS before they reached the highs they are trading at today.Just follow this link here! About R1 RCM Stock (NASDAQ:RCM)R1 RCM Inc. provides technology-driven solutions for the financial performance and patient experience of health systems, hospitals, and physician groups. It provides operating partnership/end-to-end solutions, which manages multiple aspects of the revenue cycle to realize financial leverage and revenue improvement for hospital and physician customers. The company also offers modular solutions, including functional partnership, an outsourcing solutions for improvements across targeted revenue cycle areas for hospital and physician group customers; revenue recovery, to fast-track payer and patient cash collections; revenue optimization, a solution to uncover missed or underreported revenue; clinical integrity, used to improve documentation and coding accuracy to maximize earned revenue for the services provided; and regulatory navigation, a compliance-first solutions for government reimbursement accuracy, pharmacy savings, and compliance. The company was incorporated in 2003 and is headquartered in Murray, Utah.Read More RCM Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart RCM Stock News HeadlinesJuly 24 at 1:13 PM | markets.businessinsider.comHold Rating Maintained Amid R1 RCM Acquisition Uncertainties and Market ReactionsJuly 24 at 8:00 AM | globenewswire.comR1 RCM Special Committee Provides Update on Evaluation of Strategic AlternativesJuly 26, 2024 | DTI (Ad)How a $0.25 cent option contract makes my top traders feelIf you don’t know me, I’ve been in the markets for over 40 years… but recently, I’ve discovered a breakthrough that might be my favorite strategy of ALL time! While I kept the finer details of these $0.25 Cent Trades under wraps until recently…July 24 at 6:06 AM | globenewswire.comRCM STOCKHOLDER ALERT: R1 RCM Inc. (Nasdaq:RCM) Shareholders are Notified that BFA Law is Investigating the Merger Agreement and are Urged to Contact the FirmJuly 23 at 10:10 PM | ca.finance.yahoo.comRCM Aug 2024 14.000 callJuly 23 at 1:39 AM | markets.businessinsider.comUnveiling 8 Analyst Insights On R1 RCMJuly 22, 2024 | americanbankingnews.comR1 RCM's (RCM) "Buy" Rating Reiterated at Canaccord Genuity GroupJuly 22, 2024 | globenewswire.comRCM ONGOING INVESTIGATION: BFA Law Reminds R1 RCM Inc. (Nasdaq:RCM) Stockholders to Contact Us about Continuing Investigation into the MergerJuly 26, 2024 | DTI (Ad)How a $0.25 cent option contract makes my top traders feelIf you don’t know me, I’ve been in the markets for over 40 years… but recently, I’ve discovered a breakthrough that might be my favorite strategy of ALL time! While I kept the finer details of these $0.25 Cent Trades under wraps until recently…July 22, 2024 | globenewswire.comRCM ONGOING INVESTIGATION: BFA Law Reminds R1 RCM Inc. (Nasdaq:RCM) Stockholders to Contact Us about Continuing Investigation into the MergerJuly 20, 2024 | globenewswire.comRCM LEGAL NEWS: BFA Law Alerts R1 RCM Inc. (Nasdaq:RCM) Shareholders it is Investigating the Upcoming Transaction and Notifies Stockholders to Contact UsJuly 20, 2024 | americanbankingnews.comTraders Buy High Volume of R1 RCM Put Options (NASDAQ:RCM)July 19, 2024 | finance.yahoo.comTowerBrook, CD&R Consider Joining Forces to Bid for R1 RCMJuly 19, 2024 | finance.yahoo.comTowerBrook, CD&R in Advanced Talks to Make Offer for Health IT Firm R1 RCMJuly 19, 2024 | americanbankingnews.comR1 RCM Inc. (NASDAQ:RCM) Receives Consensus Rating of "Moderate Buy" from BrokeragesJuly 16, 2024 | globenewswire.comRCM SHAREHOLDER NOTIFICATION: R1 RCM Inc. (Nasdaq:RCM) Investors are Urged to Contact BFA Law about Investigation into the $13.25 Per Share OfferJuly 15, 2024 | globenewswire.comR1 RCM to Release Second Quarter 2024 Results on August 7, 2024July 13, 2024 | globenewswire.comRCM INVESTOR NOTICE: R1 RCM Inc. (NASDAQ:RCM) Shareholders are Notified to Contact BFA Law about Investigation into the $13.25 Per Share OfferSee More Headlines Receive RCM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for R1 RCM and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/08/2024Today7/26/2024Next Earnings (Confirmed)8/07/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorBusiness Services Industry Management services Sub-IndustryHealth Care Services Current SymbolNASDAQ:RCM Previous SymbolNYSE:RCM CUSIP00438V10 CIK1472595 Webwww.r1rcm.com Phone(312) 324-7820Fax302-655-5049Employees30,000Year Founded2003Price Target and Rating Average Stock Price Target$16.00 High Stock Price Target$20.00 Low Stock Price Target$11.00 Potential Upside/Downside+23.0%Consensus RatingModerate Buy Rating Score (0-4)2.60 Research Coverage15 Analysts Profitability EPS (Most Recent Fiscal Year)($0.08) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$3.30 million Net Margins-1.39% Pretax Margin-0.66% Return on Equity-1.16% Return on Assets-0.62% Debt Debt-to-Equity Ratio0.78 Current Ratio1.79 Quick Ratio1.79 Sales & Book Value Annual Sales$2.31 billion Price / Sales2.37 Cash Flow$0.68 per share Price / Cash Flow19.19 Book Value$6.56 per share Price / Book1.98Miscellaneous Outstanding Shares421,255,000Free Float266,233,000Market Cap$5.48 billion OptionableOptionable Beta0.85 Social Links The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.Get This Free Report Key ExecutivesMr. Lee Rivas (Age 49)CEO & Director Comp: $1.92MMr. John M. Sparby (Age 48)President Comp: $1.46MMs. Jennifer Williams (Age 47)Executive VP, CFO & Treasurer Comp: $1.13MMr. Kyle A. Hicok (Age 44)Executive VP & Chief Commercial Officer Comp: $856.58kMs. Pamela L. Spikner (Age 47)Principal Accounting Officer & Chief Accounting Officer Evan Smith C.F.A.Senior Vice President of Finance & Investor RelationsMr. Corey PermanExecutive Vice President of Compliance & RiskMr. Sean RadcliffeExecutive VP, General Counsel & Corporate SecretaryMs. Kate SandersonExecutive VP & Chief Human Resources OfficerMr. David StrickleExecutive Vice President of IntegrationMore ExecutivesKey CompetitorsTerminix GlobalNYSE:TMXManTech InternationalNASDAQ:MANTLaboratory Co. of AmericaNYSE:LHQuest DiagnosticsNYSE:DGXDaVitaNYSE:DVAView All CompetitorsInsiders & InstitutionsBank of New York Mellon CorpSold 857,370 shares on 7/26/2024Ownership: 1.076%Retirement Systems of AlabamaSold 3,108 shares on 7/24/2024Ownership: 0.058%SG Americas Securities LLCBought 16,992 shares on 7/12/2024Ownership: 0.004%QRG Capital Management Inc.Bought 1,080 shares on 7/12/2024Ownership: 0.003%Boston PartnersBought 2,519,739 shares on 5/28/2024Ownership: 0.610%View All Insider TransactionsView All Institutional Transactions RCM Stock Analysis - Frequently Asked Questions How have RCM shares performed this year? R1 RCM's stock was trading at $10.57 at the start of the year. Since then, RCM shares have increased by 23.0% and is now trading at $13.0050. View the best growth stocks for 2024 here. How were R1 RCM's earnings last quarter? R1 RCM Inc. (NASDAQ:RCM) posted its quarterly earnings data on Wednesday, May, 8th. The healthcare provider reported ($0.08) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.05) by $0.03. The business's revenue for the quarter was up 10.7% on a year-over-year basis. What is Joseph Flanagan's approval rating as R1 RCM's CEO? 253 employees have rated R1 RCM Chief Executive Officer Joseph Flanagan on Glassdoor.com. Joseph Flanagan has an approval rating of 70% among the company's employees. Does R1 RCM have any subsidiaries? R1 RCM subsidiaries include these companies: Cloudmed, VisitPay, Cerner RevWorks, SCI Solutions, Intermedix, Accretive Health Mauritius Inc., cGate Health Inc., and more. Who are R1 RCM's major shareholders? Top institutional shareholders of R1 RCM include Bank of New York Mellon Corp (1.08%), Retirement Systems of Alabama (0.06%), SG Americas Securities LLC and QRG Capital Management Inc.. Insiders that own company stock include Achi Series Lllp Tcp-Asc, Joseph Gerard Flanagan, John M Sparby, Richard B Jr Evans, John B Henneman III, Lee Rivas and Alex Mandl. View institutional ownership trends. How do I buy shares of R1 RCM? Shares of RCM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of R1 RCM own? Based on aggregate information from My MarketBeat watchlists, some other companies that R1 RCM investors own include NVIDIA (NVDA), JD.com (JD), Baozun (BZUN), Inseego (INSG), BioXcel Therapeutics (BTAI), Marvell Technology (MRVL) and Akoustis Technologies (AKTS). This page (NASDAQ:RCM) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | Sponsored5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding R1 RCM Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share R1 RCM With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
